Skip to content

Clinical study on the effect of epidural analgesia with low concentration and high volume ropivacaine combined with sufentanil on vaginal delivery

Clinical study on the effect of epidural analgesia with low concentration and high volume ropivacaine combined with sufentanil on vaginal delivery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083141
Enrollment
Unknown
Registered
2024-04-16
Start date
2024-04-26
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Group A:0.075% ropivacaine +0.3ug/ml sufentanil +0.9% normal saline to 100 ml, pulse amount 10 ml/ time, PCA 10 ml, interval 40 min
Group B:0.15% ropivacaine +0.6 ug/ml sufentanyl +0.9% normal saline to 100 ml, pulse volume 5 ml/ time, PCA 5 ml, interval time 40 min.

Sponsors

Hunan Provincial Maternal And Child Health Care Hospital(Hunan Institute of Reproductive Medicine)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Nulliparous ,Vertex presentation and full-term pregnancy; (2) ASA I or II ; (3) Cervical dilation < 5cm at the time of request for epidural analgesia ; (4) No prior use of pain medicine and magnesium ; (5) The research consent has been signed, which can cooperate with the parturient who completed the research.

Exclusion criteria

Exclusion criteria: The reasons for not performing epidural labor analgesia include spinal trauma or deformity, coagulation dysfunction, refusal of labor analgesia; (2) BMI > 35; (3) delivery within 4 hours of epidural catheterization; (4) fetal malformation.

Design outcomes

Primary

MeasureTime frame
PCA press times;

Secondary

MeasureTime frame
VAS scole at each time piont;Vaginal delivery rate;Instrument assisted delivery rate;Cesarean section rate;Duration of the first and second stages of labor;Maternal satisfaction score;Bromage rating;Maternal side effects;Neonatal outcome;

Countries

China

Contacts

Public ContactTao Han

Hunan Provincial Maternal And Child Health Care Hospital(Hunan Institute of Reproductive Medicine)

790673909@qq.com+86 134 6763 0345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026